Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Avantogen Oncology, Inc.    AVTO

Delayed Quote. Delayed  - 11/10 09:58:53 pm
0.01039 USD   -13.42%
 SummaryQuotesChartsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
09/19/2017 09/25/2017 11/10/2017 11/28/2017 11/10/2017 Date
0.0066(c) 0.012(c) 0.01039(c) 0(c) 0.01039 Last
1 500 16 000 0 3 2 000 Volume
-45.00% +81.82% -13.42% -100.00% -13.42% Change
More quotes
Company
Avantogen Oncology, Inc. operates as a development stage company.It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer.The company was founded in 1986 and is headquartered in Los Angeles, CA. 
More about the company
Latest news on AVANTOGEN ONCOLOGY, INC.

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
12/12 M&A "boom" dominates Europe share trading as oil leads gains
12/12 Sanofi investors hungry for drug progress and deal news
12/08 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Biotechnology & Medical Research - NEC
Chart AVANTOGEN ONCOLOGY, INC.
Duration : Period :
Avantogen Oncology, Inc. Technical Analysis Chart | AVTO | US05350Y1001 | 4-Traders
Managers
NameTitle
William J. Ardrey Chairman, President & Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
AVANTOGEN ONCOLOGY, INC.107.80%0
CELLTRION, INC.--.--%23 085
IQVIA HOLDINGS INC32.70%21 148
INCYTE CORPORATION-5.43%20 523
LONZA GROUP57.44%19 299
ALNYLAM PHARMACEUTICALS, INC.243.83%12 606